Johnson & Johnson (JNJ) Short-term Investments (2009 - 2026)

Johnson & Johnson has disclosed Short-term Investments across 18 years of filings, most recently posting $336.0 million for Q2 2026.

• In Q2 2026, Short-term Investments rose 10.89% year-over-year to $336.0 million; the TTM figure through Jun 2026 stood at $336.0 million (up 10.89% YoY), while the FY2025 annual figure was $393.0 million, down 5.76% from the prior year.
• Short-term Investments came in at $336.0 million for Q2 2026 at Johnson & Johnson, down from $363.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $22.7 billion in Q4 2022 to a low of $303.0 million in Q2 2025.
• Average Short-term Investments over 5 years is $5.9 billion, with a median of $745.0 million recorded in 2024.
• Year-over-year, Short-term Investments jumped 96.69% in 2022 and plunged 91.85% in 2024.
• Over 5 years, Short-term Investments stood at $22.7 billion in 2022, then plunged by 95.3% to $1.1 billion in 2023, then tumbled by 60.96% to $417.0 million in 2024, then declined by 5.76% to $393.0 million in 2025, then dropped by 14.5% to $336.0 million in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $336.0 million in Q2 2026, $363.0 million in Q1 2026, and $393.0 million in Q4 2025.